(Q83992836)
Statements
First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07) (English)
Swiss Group for Clinical Cancer Research (SAKK)
R von Moos
B Seifert
M Simcock
S M Goldinger
A Ochsenbein
O Michielin
R Cathomas
M Schläppi
H Moch
P H Schraml
D Mjhic-Probst
N Schönewolf
28 April 2011